Addiction Treatment Market Share, Trends, Analysis and Forecasts, 2020 – 2030
The global addiction treatment market is growing significantly owing to spreading awareness and stringent government regulations on the sale of prescription drugs worldwide. The government authorities and drug manufacturers are actively engaged in promoting the addiction treatment and spreading awareness regarding the ill effects of alcohol and drugs. According to the National Survey on Drug Use and Health (NSDUH) 2017 statistics, around 20 million American adults were suffering from drug use disorder costing approximately US$ 740 billion in workplace productivity, healthcare expenses, and crime-related costs. The major cause of addiction is anticipated to be the misuse of medications, which has fueled the implementation of stringent regulations over the purchase of medication in major parts of the world. Additionally, reimbursement through insurance for prescription drugs such as Chantix and Zyban is playing a crucial role in the adoption of addition treatments. The global addiction treatment market is expected to witness prominent growth during the forecast period.
Request a PDF Sample Report: https://www.insightslice.com/request-sample/340
North America contributed the largest share to the global addiction treatment market in 2019 owing to increasing awareness regarding addiction treatment, stringent regulations on purchase of medication, and favorable reimbursement policies. The presence of leading manufacturers of addiction treatment medication, and government initiatives to spread awareness regarding the health hazards of over consumption of opioids are expected to drive the North America addition treatment market during the forecast period. Asia Pacific is anticipated to be the fastest growing addiction treatment market owing to increasing adoption of alcohol addiction treatment. Expanding pharmaceutical manufacturing industry and promotion of natural therapies for addiction treatment are anticipated to contribute towards the growth of addiction treatment market in coming years.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, GlaxoSmithKline plc reported revenues of USD 41,974.1 million in 2019 and the product segment analysis of the company indicates that Pharmaceuticals business segment of the company dominated revenue in 2019 with North America being the largest revenue contributing geography under the Pharmaceutical business segment.
The global addiction treatment market is segmented based on treatment type, drug type, treatment center, sales channel, and geography. Based on treatment type, the global addiction treatment market is segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, opioid addiction treatment, and other. Based on drug type, the global addiction treatment market is segmented into bupropion, varenicline, acamprosate, disulfiram, naltrexone, methadone, buprenorphine, nicotine replacement products, and others. Based on treatment center, the global addiction treatment market is segmented into outpatient treatment center, residential treatment center, and inpatient treatment center.. Based on geography, the global addiction treatment market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
Buy Now Report with Exclusive Discount: https://www.insightslice.com/request-discount/340
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on addiction treatment products. Further, market share of prominent companies in the global addiction treatment market would also be estimated. For instance, GlaxoSmithKline plc operates through three business segments namely Pharmaceuticals, Vaccines, and Consumer Health. The addiction treatment products are delivered under Pharmaceuticals business segment of the company with revenue contribution of US$ 21,860.0 million in 2019.